Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares
Derek J. Maetzold, CEO of Castle Biosciences Inc., reported selling common shares of the company. The information was published via EDGAR by Castle Biosciences and is available for review. This brief was generated by Public Technologies using AI and is not financial advice.
Derek J. Maetzold, President and Chief Executive Officer of Castle Biosciences Inc., reported a disposal of common shares of Castle Biosciences Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-054431), on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
